Tom Cheever

Tom Cheever, Ph.D.

Program Director

Division:
Division of Neuroscience
Cluster:
Neurodegeneration
Areas of Interest:
  • Frontotemporal dementia (FTD), including progressive supranuclearpalsy (PSP)
  • Structural, molecular, biochemical, and cellular aspects of Parkinson’sdisease (PD) as it relates to protein aggregation, mitochondria, andprotein processing
  • Genetic, epidemiology, imaging biomarker, and clinical studies in PD

Dr. Tom Cheever serves as a Program Director in the Neurodegeneration Cluster of the Division of Neuroscience at NINDS. His portfolio includes Frontotemporal dementia as well as components of the Parkinson's disease portfolio as outlined above. Dr. Cheever also serves on several Trans-NIH committees including as a co-chair for the NIH's contributions to the Sound Health Initiative exploring the impact of music on the brain and overall health. Prior to joining NINDS, Dr. Cheever was the program director for muscle disorders and therapies at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). While at NIAMS, Dr. Cheever was also a project team lead for the NIH Common Fund's Somatic Cell Genome Editing Consortium. Prior to this, Dr. Cheever was a Health Science Policy Analyst and American Association for the Advancement of Science (AAAS) Science and Technology Policy Fellow at the NINDS Office of Science Policy and Planning where he contributed to several portfolio analyses, evaluations, and reports. Dr. Cheever completed his postdoctoral training at the Mayo Clinic and graduate training in Biochemistry, Molecular Biology, and Biophysics at the University of Minnesota where he conducted research on the role of the actin cytoskeleton in neuronal development and function.